Investors

STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. More than 3,000,000 ICLs have been sold to date.

Learn More

Who is STAAR Surgical?

who is staar

Latest Presentation

Why Invest?

icon 1

180 Million+ Eye TAM

icon 2

Strong Revenue Growth via Market Share Gains and Creation

icon 3

Proprietary and Premium family of ICL lenses with R&D Pipeline

icon 4

99.4% Patient Satisfaction*

icon 5

Demonstrated Financial Discipline and Strong Balance Sheet

*Patient EVO Visian ICL registry data on file.

Press Releases

View All Press Releases

Key Metrics